INTREPID study: Once-daily single-inhaler fluticasone furoate/umeclidinium/vilanterol vs multiple-inhaler triple therapy; sub-analysis by prior medication strata
C. Compton (Brentford, Middlesex, United Kingdom), S. Worsley (Stevenage, Hertfordshire, United Kingdom), D. Midwinter (Stockley Park West, Uxbridge, Middlesex, United Kingdom), A. Ismaila (Collegeville, PA (USA) and Hamilton, ON (Canada), United States of America), K. Beeh (Wiesbaden, Germany), V. Di Boscio (Brentford, Middlesex, United Kingdom), J. Kocks (Groningen (Netherlands), Groningen (Netherlands) and Singapore (Singapore), Netherlands), J. Marin (Zaragoza, Spain), M. Tabberer (Stockley Park West, Uxbridge, Middlesex, United Kingdom), N. Snowise (Brentford, Middlesex and London, United Kingdom), D. Halpin (Exeter, United Kingdom)
Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Compton (Brentford, Middlesex, United Kingdom), S. Worsley (Stevenage, Hertfordshire, United Kingdom), D. Midwinter (Stockley Park West, Uxbridge, Middlesex, United Kingdom), A. Ismaila (Collegeville, PA (USA) and Hamilton, ON (Canada), United States of America), K. Beeh (Wiesbaden, Germany), V. Di Boscio (Brentford, Middlesex, United Kingdom), J. Kocks (Groningen (Netherlands), Groningen (Netherlands) and Singapore (Singapore), Netherlands), J. Marin (Zaragoza, Spain), M. Tabberer (Stockley Park West, Uxbridge, Middlesex, United Kingdom), N. Snowise (Brentford, Middlesex and London, United Kingdom), D. Halpin (Exeter, United Kingdom). INTREPID study: Once-daily single-inhaler fluticasone furoate/umeclidinium/vilanterol vs multiple-inhaler triple therapy; sub-analysis by prior medication strata. 981
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: